ACT-HIB

This brand name is authorized in Austria, Cyprus, Estonia, Finland, France, Hong Kong, Netherlands, New Zealand, Poland, Turkey

Active ingredients

The drug ACT-HIB contains one active pharmaceutical ingredient (API):

1 Haemophilus influenzae B

UNII FLV5I5W26R - HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN

Haemophilus influenza type B (Hib) is a bacteria responsible for severe pneumonia, meningitis and other invasive diseases almost exclusively in young children. Vaccines are the only public health tool capable of preventing the majority of serious Hib disease.

Read about Haemophilus influenzae B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

J07AG01

Haemophilus influenzae B, purified antigen conjugated

J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AG Haemophilus influenzae B vaccines

Discover more medicines within J07AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Ravimiamet

Identifier(s): 1019584

Lääkealan turvallisuus- ja kehittämiskeskus

Identifier(s): 198901

Base de données publique des médicaments

Identifier(s): 61104024

Department of Health Drug Office

Identifier(s): 37568

Z-Index G-Standaard

Identifier(s): 13901397

Z-Index G-Standaard, PRK

Identifier(s): 36471

Medicines and Medical Devices Safety Authority

Identifier(s): 6803

Rejestru Produktów Leczniczych

Identifier(s): 100224400

İlaç ve Tıbbi Cihaz Kurumu

Identifier(s): 8699625960022

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.